{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:45:38Z","timestamp":1791179138074,"version":"4.1.0"},"reference-count":42,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,10,1]]},"abstract":"<jats:p>Mantle cell lymphoma (MCL) has a chromosomal translocation resulting in the expression of the cyclin D1 gene driven by the powerful enhancer of the immunoglobulin heavy chain gene, leading to uncontrolled, overexpressed cyclin D1 protein. We showed that suberoylanilide hydroxamic acid (SAHA; vorinostat), one of the histone deacetylase inhibitors derived from hydroxamic acid, caused a dramatic decrease (90%) in protein levels of cyclin D1 after 8-hour exposure to SAHA (5 \u03bcM) in MCL lines (SP49, SP53, Jeko1). mRNA levels and protein stability of cyclin D1 were minimally affected by SAHA over 8 hours. In contrast, metabolic labeling assays showed that SAHA decreased incorporation of [35S]methionine into cyclin D1 protein. The drug also decreased levels of phosphorylated Akt, mammalian target of Rapamycin (mTOR), and eukaryotic translation initiation factor 4E binding protein (eIF4E-BP) and lowered the cap site binding activity of eIF4E in the MCL cells. In vitro phosphatidyl inositol (PI) kinase assay demonstrated that SAHA directly inhibited kinase activity of PI 3\u2032 kinase. Taken together, SAHA caused a rapid decrease of cyclin D1 in MCL by blocking the translation of cyclin D1 by inhibiting the phosphatidylinositol 3-kinase (PI3K)\/Akt\/mTOR\/eIF4E-BP pathway, probably by PI3K inhibition.<\/jats:p>","DOI":"10.1182\/blood-2005-11-026344","type":"journal-article","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T00:39:41Z","timestamp":1183423181000},"page":"2667-2673","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":90,"title":["Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells"],"prefix":"10.1182","volume":"110","author":[{"given":"Norihiko","family":"Kawamata","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Cedars-Sinai Medical Center\/University of California, Los Angeles (UCLA) School of Medicine, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Cedars-Sinai Medical Center\/University of California, Los Angeles (UCLA) School of Medicine, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Phillip","family":"Koeffler","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Cedars-Sinai Medical Center\/University of California, Los Angeles (UCLA) School of Medicine, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111813000176300_B1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2141.2003.04761.x","article-title":"Molecular basis of mantle cell lymphoma.","volume":"124","author":"Bertoni","year":"2004","journal-title":"Br J Haematol"},{"key":"2019111813000176300_B2","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1200\/JCO.2005.05.019","article-title":"Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.","volume":"23","author":"Fern\u00e0ndez","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019111813000176300_B3","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene.","volume":"13","author":"Bodrug","year":"1994","journal-title":"EMBO J"},{"key":"2019111813000176300_B4","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.","volume":"13","author":"Lovec","year":"1994","journal-title":"EMBO J"},{"key":"2019111813000176300_B5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1182\/blood.V98.3.787","article-title":"Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray.","volume":"98","author":"Hofmann","year":"2001","journal-title":"Blood"},{"key":"2019111813000176300_B6","first-page":"8226","article-title":"The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.","volume":"63","author":"Mart\u00ednez","year":"2003","journal-title":"Cancer Res"},{"key":"2019111813000176300_B7","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2004-10-3999","article-title":"Proteomic analysis of mantle-cell lymphoma by protein microarray.","volume":"105","author":"Ghobrial","year":"2005","journal-title":"Blood"},{"key":"2019111813000176300_B8","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-04-1526","article-title":"CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a\/ARF locus.","volume":"65","author":"Hern\u00e1ndez","year":"2005","journal-title":"Cancer Res"},{"key":"2019111813000176300_B9","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2004-10-3907","article-title":"Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome.","volume":"105","author":"Rubio-Moscardo","year":"2005","journal-title":"Blood"},{"key":"2019111813000176300_B10","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1182\/blood-2004-07-2730","article-title":"Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization.","volume":"105","author":"Schraders","year":"2005","journal-title":"Blood"},{"key":"2019111813000176300_B11","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1200\/JCO.2005.55.017","article-title":"Current treatment approaches for mantle-cell lymphoma.","volume":"23","author":"Witzig","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019111813000176300_B12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exphem.2004.09.008","article-title":"Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines.","volume":"33","author":"Sakajiri","year":"2005","journal-title":"Experimental Hematology"},{"key":"2019111813000176300_B13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.2005.00546.x","article-title":"Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.","volume":"76","author":"Heider","year":"2006","journal-title":"Eur J Haematol"},{"key":"2019111813000176300_B14","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1016\/S0021-9258(18)53358-5","article-title":"The p46 subunit of eukaryotic initiation factor (eIF)-4F exchanges with eIF-4A.","volume":"268","author":"Yoder-Hill","year":"1993","journal-title":"J Biol Chem"},{"key":"2019111813000176300_B15","doi-asserted-by":"crossref","first-page":"27549","DOI":"10.1074\/jbc.M313435200","article-title":"Stabilization of p53 is a novel mechanism for proapoptotic function of NF-\u03baB.","volume":"279","author":"Fujioka","year":"2004","journal-title":"J Biol Chem"},{"key":"2019111813000176300_B16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1101\/gad.1189704","article-title":"Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1).","volume":"18","author":"Daly","year":"2004","journal-title":"Genes Dev"},{"key":"2019111813000176300_B17","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1074\/jbc.275.9.6267","article-title":"The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity.","volume":"275","author":"Aoki","year":"2000","journal-title":"J Biol Chem"},{"key":"2019111813000176300_B18","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1128\/MCB.20.15.5469-5478.2000","article-title":"The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase.","volume":"20","author":"Genot","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2019111813000176300_B19","doi-asserted-by":"crossref","first-page":"10964","DOI":"10.1074\/jbc.M407874200","article-title":"Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway.","volume":"280","author":"Shi","year":"2005","journal-title":"J Biol Chem"},{"key":"2019111813000176300_B20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers.","volume":"304","author":"Samuels","year":"2004","journal-title":"Science"},{"key":"2019111813000176300_B21","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","article-title":"A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).","volume":"269","author":"Vlahos","year":"1994","journal-title":"J Biol Chem"},{"key":"2019111813000176300_B22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family.","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem J"},{"key":"2019111813000176300_B23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1101\/gad.11.8.957","article-title":"Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.","volume":"11","author":"Diehl","year":"1997","journal-title":"Genes Dev"},{"key":"2019111813000176300_B24","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1038\/sj.onc.1208326","article-title":"Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis.","volume":"24","author":"Guo","year":"2005","journal-title":"Oncogene"},{"key":"2019111813000176300_B25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.onc.1208225","article-title":"Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM).","volume":"24","author":"Yin","year":"2005","journal-title":"Oncogene"},{"key":"2019111813000176300_B26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cell.2004.12.040","article-title":"The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.","volume":"120","author":"Beuvink","year":"2005","journal-title":"Cell"},{"key":"2019111813000176300_B27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(04)00115-1","article-title":"Translational control by MAPK signaling in long-term synaptic plasticity and memory.","volume":"116","author":"Kelleher","year":"2004","journal-title":"Cell"},{"key":"2019111813000176300_B28","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.1128\/MCB.13.12.7358","article-title":"Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E.","volume":"13","author":"Rosenwald","year":"1993","journal-title":"Mol Cell Biol"},{"key":"2019111813000176300_B29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1357-2725(98)00131-9","article-title":"eIF4E activity is regulated at multiple levels.","volume":"31","author":"Raught","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"2019111813000176300_B30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1101\/gad.887201","article-title":"Regulation of translation initiation by FRAP\/mTOR.","volume":"15","author":"Gingras","year":"2001","journal-title":"Genes Dev"},{"key":"2019111813000176300_B31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"PI3K\/Akt signalling pathway and cancer.","volume":"30","author":"Fresno Vara","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"2019111813000176300_B32","first-page":"2720","article-title":"Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.","volume":"58","author":"Vlietstra","year":"1998","journal-title":"Cancer Res"},{"key":"2019111813000176300_B33","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1038\/sj.onc.1209096","article-title":"Akt-regulated pathways in prostate cancer.","volume":"24","author":"Majumder","year":"2005","journal-title":"Oncogene"},{"key":"2019111813000176300_B34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","article-title":"Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways.","volume":"130","author":"Rizzatti","year":"2005","journal-title":"Br J Haematol"},{"key":"2019111813000176300_B35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nm1042","article-title":"The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis.","volume":"10","author":"Ruggero","year":"2004","journal-title":"Nat Med"},{"key":"2019111813000176300_B36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy.","volume":"428","author":"Wendel","year":"2004","journal-title":"Nature"},{"key":"2019111813000176300_B37","first-page":"269","article-title":"Inhibition of EGFR\/PI3K\/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.","volume":"29","author":"Zhou","year":"2006","journal-title":"Int J Oncol"},{"key":"2019111813000176300_B38","first-page":"477","article-title":"Suppression of phosphatidylinositol 3-kinase\/Akt signaling pathway is a determinant of the sensitivity to a novel histone deacetylase inhibitor, FK228, in lung adenocarcinoma cells.","volume":"13","author":"Kodani","year":"2005","journal-title":"Oncol Rep"},{"key":"2019111813000176300_B39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/path.1727","article-title":"Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms.","volume":"205","author":"Carreras","year":"2005","journal-title":"J Pathol"},{"key":"2019111813000176300_B40","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood.V96.6.2219","article-title":"Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures.","volume":"96","author":"Andersen","year":"2000","journal-title":"Blood"},{"key":"2019111813000176300_B41","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/sj.leu.2401829","article-title":"Mantle cell lymphoma proliferates upon IL-10 in the CD40 system.","volume":"14","author":"Visser","year":"2000","journal-title":"Leukemia"},{"key":"2019111813000176300_B42","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1074\/jbc.M309999200","article-title":"AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression.","volume":"279","author":"Gera","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/7\/2667\/484253\/zh801907002667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/7\/2667\/484253\/zh801907002667.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T13:30:32Z","timestamp":1629120632000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/110\/7\/2667\/103642\/Suberoylanilide-hydroxamic-acid-SAHA-vorinostat"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,1]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-11-026344","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,1]]}}}